Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Utilising the extensive range of data assets exclusively available to IQVIA, combined with our market leading expertise, we are able to support the NHS meet the challenge of delivering high quality, efficient and cost effective healthcare by identifying actionable insight and realising the value in data.
Learn MoreWe believe in the UK’s potential to become a global leader in the life sciences sector, and our investments announced in the 2018 Second Life Sciences Sector Deal further support the UK Government and the industry’s aim to make that potential a reality.
Learn MoreWe are committed to providing solutions that inform and enable all stakeholders across UK healthcare, to innovate with confidence, maximise opportunities, and, ultimately, drive human health outcomes forward.
Learn More
IQVIA’s Pharmacy Communications offers pharma companies a simple and cost-effective channel to communicate product changes, updates and patient advice directly to patients via pharmacists.
Learn MoreExplore our library of resources spanning the healthcare & life science ecosystem on the latest topics, trends, and market developments that matter to you.
Learn MoreThe IQVIA Value and Access team works to drive engagement between the NHS and the Life Science Industry to facilitate crucial discussions with key decision makers to accelerate and optimise patient access to innovative technologies.
Unique access to the most robust insights and data assets in the industry, including:
Connected expertise of trusted IQVIA Market Access & Patient Access (MAPA) consultants, Infield market access teams, wider subject matter experts, and a unique network of 110,000 clinicians and managers in the NHS, giving unparalleled breadth and depth of understanding across the healthcare system and life science industry
Tried and tested methodology, with multiple landscape assessments completed across a range of disease areas in all core life science sectors:
The Private Healthcare Market can bring the potential opportunity for the Life Science Industry to capture up to 10% of total revenue within the private sector. An opportunity for the private market to catalyse and accelerate the activation of a much larger opportunity in routine NHS commissioning.
Our IQVIA team discuss the UK Private market and the growing opportunities this brings for the life sciences industry. Watch the full video below with Steve Jowett, Steve Ferguson, Arlene Neville and Orlaith Brennan sharing their insights
Find out about the key opportunities and benefits the UK Private Market can bring for your business
Helping brand teams inform NHS payers of pre-licensed product launches for budget and service planning
Quantify the Opportunity
Transform the Pathway
Implement the Change
Identify the Patient
Support the Patient
